Physician profile
Mesha Mathis
NPI 1215094982
$989.03
in general payments reported to CMS, 2019-2025
25 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $540 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $146.56 | 2025 | Pico |
| Vertex Pharmaceuticals Incorporated | $125.90 | 2025 | |
| Merck Sharp & Dohme LLC | $99.09 | 2022-2025 | Lynparza, Keytruda |
| Morphosys, US INC. | $88.09 | 2022 | |
| Amgen INC. | $44.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.25 | 2022 | |
| Janssen Biotech, INC. | $38.71 | 2025 | Rybrevant |
| Blueprint Medicines Corporation | $37.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.43 | 2022 | |
| Myriad Genetic Laboratories, INC. | $34.32 | 2025 | Myrisk |
| Coherus Oncology, INC. | $28.53 | 2022 | |
| Daiichi Sankyo INC. | $24.28 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $22.09 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.05 | 2022 | |
| Aveo Pharmaceuticals, INC. | $21.25 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $21.21 | 2025 | Nimbl, Flexitouch Plus |
| Rigel Pharmaceuticals, INC. | $20.22 | 2022 | |
| Seagen INC. | $19.43 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.39 | 2022 | |
| Puma Biotechnology, INC. | $18.14 | 2022 | |
| Tersera Therapeutics LLC | $17.53 | 2022 | |
| Pharmacosmos Therapeutics INC. | $16.09 | 2022 | |
| Agios Pharmaceuticals, INC. | $15.94 | 2022 | |
| Olympus America INC. | $15.42 | 2025 | Olympus |
| Integra Lifesciences Corporation | $14.15 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mesha Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.